Ferenc Folláth

23.1k total citations · 3 hit papers
202 papers, 11.3k citations indexed

About

Ferenc Folláth is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Ferenc Folláth has authored 202 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Cardiology and Cardiovascular Medicine, 30 papers in Pharmacology and 26 papers in Molecular Biology. Recurrent topics in Ferenc Folláth's work include Heart Failure Treatment and Management (66 papers), Cardiovascular Function and Risk Factors (35 papers) and Cardiac pacing and defibrillation studies (33 papers). Ferenc Folláth is often cited by papers focused on Heart Failure Treatment and Management (66 papers), Cardiovascular Function and Risk Factors (35 papers) and Cardiac pacing and defibrillation studies (33 papers). Ferenc Folláth collaborates with scholars based in Switzerland, France and United Kingdom. Ferenc Folláth's co-authors include John G.F. Cleland, Michel Komajda, Markku S. Nieminen, Luigi Tavazzi, Karl Swedberg, Antonello Gavazzi, J Korewicki, Piotr Ponikowski, Helmut Drexler and José López‐Sendón and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ferenc Folláth

193 papers receiving 10.7k citations

Hit Papers

Guidelines for the diagnosis and treatment of chronic hea... 2002 2026 2010 2018 2005 2006 2002 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
    2005 1.7k citations Karl Swedberg, John G.F. Cleland et al. European Heart Journal profile →
  2. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
    2006 901 citations Markku S. Nieminen, Ferenc Folláth et al. European Heart Journal profile →
  3. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
    2002 777 citations Ferenc Folláth, John G.F. Cleland et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferenc Folláth Switzerland 48 7.9k 1.6k 1.2k 1.1k 1.0k 202 11.3k
Evan Loh United States 37 7.9k 1.0× 1.8k 1.2× 1.4k 1.2× 1.0k 0.9× 847 0.8× 90 11.3k
Ali Ahmed United States 57 7.6k 1.0× 1.5k 1.0× 1.7k 1.4× 941 0.9× 798 0.8× 369 11.3k
José Antônio Franchini Ramires Brazil 45 5.4k 0.7× 3.4k 2.2× 965 0.8× 1.3k 1.2× 535 0.5× 486 9.5k
John D. Horowitz Australia 60 9.1k 1.1× 1.5k 0.9× 1.1k 0.9× 1.2k 1.1× 328 0.3× 380 13.5k
Keld Kjeldsen Denmark 41 11.4k 1.4× 3.0k 1.9× 1.1k 0.9× 721 0.7× 621 0.6× 130 15.0k
James E. Dalen United States 63 11.9k 1.5× 5.3k 3.4× 2.1k 1.7× 2.1k 1.9× 815 0.8× 204 18.4k
José López‐Sendón Spain 56 10.0k 1.3× 4.1k 2.6× 1.3k 1.1× 1.2k 1.1× 656 0.7× 263 13.6k
Eric L. Michelson United States 58 17.7k 2.2× 2.0k 1.3× 2.3k 1.9× 1.1k 1.0× 687 0.7× 192 20.9k
Fred S. Apple United States 74 14.5k 1.8× 4.4k 2.8× 1.1k 0.9× 1.2k 1.1× 850 0.8× 369 21.0k
Emil Loldrup Fosbøl Denmark 56 5.2k 0.7× 2.0k 1.3× 775 0.6× 1.8k 1.6× 631 0.6× 420 11.1k

Countries citing papers authored by Ferenc Folláth

Since Specialization
Citations

This map shows the geographic impact of Ferenc Folláth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferenc Folláth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferenc Folláth more than expected).

Fields of papers citing papers by Ferenc Folláth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferenc Folláth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferenc Folláth. The network helps show where Ferenc Folláth may publish in the future.

Co-authorship network of co-authors of Ferenc Folláth

This figure shows the co-authorship network connecting the top 25 collaborators of Ferenc Folláth. A scholar is included among the top collaborators of Ferenc Folláth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferenc Folláth. Ferenc Folláth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rickenbacher, Peter, Matthias Pfisterer, Thilo Burkard, et al.. (2012). Why and How do Elderly Patients with Heart Failure Die? Insights from the TIME-CHF Study. European Journal of Heart Failure. 14(11). 1218–1229. 26 indexed citations
2.
Funck‐Brentano, Christian, Dirk J. van Veldhuisen, Louis L.M. van de Ven, et al.. (2011). Influence of Order and Type of Drug (Bisoprolol vs. Enalapril) on Outcome and Adverse Events in Patients with Chronic Heart Failure: A post hoc Analysis of the CIBIS-III Trial. European Journal of Heart Failure. 13(7). 765–772. 20 indexed citations
3.
Castagno, Davide, Erland Erdmann, Faı̈ez Zannad, et al.. (2011). Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II). Cardiovascular Drugs and Therapy. 25(1). 77–85. 10 indexed citations
4.
Yılmaz, Mehmet Birhan, Étienne Gayat, Johan Lassus, et al.. (2011). Impact of Diuretic Dosing on Mortality in Acute Heart Failure Using a Propensity-Matched Analysis. European Journal of Heart Failure. 13(11). 1244–1252. 43 indexed citations
5.
Castagno, Davide, Pardeep S. Jhund, John J.V. McMurray, et al.. (2010). Improved Survival with Bisoprolol in Patients with Heart Failure and Renal Impairment: An Analysis of the Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) Trial. European Journal of Heart Failure. 12(6). 607–616. 62 indexed citations
6.
Parissis, John, Maria Nikolaou, Alexandre Mebazaa, et al.. (2010). Acute Pulmonary Oedema: Clinical Characteristics, Prognostic Factors, and in-Hospital Management. European Journal of Heart Failure. 12(11). 1193–1202. 41 indexed citations
7.
Mebazaa, Alexandre, Antoniοs Pitsis, Alain Rudiger, et al.. (2010). Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Critical Care. 14(2). 201–201. 140 indexed citations
8.
Mebazaa, Alexandre, Mihai Gheorghiade, Ileana L. Piña, et al.. (2008). Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Critical Care Medicine. 36(Suppl). S129–S139. 182 indexed citations
9.
Nieminen, Markku S., Veli‐Pekka Harjola, Matthias Hochadel, et al.. (2008). Gender Related Differences in Patients Presenting with Acute Heart Failure. Results from EuroHeart Failure Survey II. European Journal of Heart Failure. 10(2). 140–148. 130 indexed citations
10.
Lainščak, Mitja, John G.F. Cleland, Mattie Lenzen, et al.. (2007). Recall of Lifestyle Advice in Patients Recently Hospitalised with Heart Failure: A EuroHeart Failure Survey Analysis. European Journal of Heart Failure. 9(11). 1095–1103. 49 indexed citations
11.
Lainščak, Mitja, John G.F. Cleland, Mattie Lenzen, et al.. (2006). International Variations in the Treatment and Co-Morbidity of Left Ventricular Systolic Dysfunction: Data from the EuroHeart Failure Survey. European Journal of Heart Failure. 9(3). 292–299. 57 indexed citations
12.
Rudiger, Alain, Veli‐Pekka Harjola, Andreas Müller, et al.. (2005). Acute Heart Failure: Clinical Presentation, One-Year Mortality and Prognostic Factors. European Journal of Heart Failure. 7(4). 662–670. 134 indexed citations
13.
Muntwyler, Jörg, Alain Cohen‐Solal, Nick Freemantle, et al.. (2004). Relation of Sex, Age and Concomitant Diseases to Drug Prescription for Heart Failure in Primary Care in Europe. European Journal of Heart Failure. 6(5). 663–668. 47 indexed citations
14.
Willenheimer, Ronnie, Erland Erdmann, Ferenc Folláth, et al.. (2004). Comparison of Treatment Initiation with Bisoprolol Vs. Enalapril in Chronic Heart Failure Patients: Rationale and Design of CIBIS-III. European Journal of Heart Failure. 6(4). 493–500. 25 indexed citations
15.
Cleland, John G.F., et al.. (2001). Diagnosis of heart failure in Europe: a survey of perceptions and practice from over 1300 physicians and over 11,000 of their patients. European Heart Journal. 22. 144–144. 1 indexed citations
16.
Cleland, John G.F., Ferenc Folláth, Karl Swedberg, et al.. (2001). Variations in therapy for heart failure in Europe: from perceptions to practice. A study of over 1300 physicians and > 11,000 patients. European Heart Journal. 22. 536–536. 1 indexed citations
17.
Drexel, Heinz, et al.. (2001). Effects of Bisoprolol on Lipoprotein Cholesterol Subfractions and Apolipoproteins in Patients with Hypertension. Journal of clinical and basic cardiology. 4(1). 57–60. 1 indexed citations
18.
Cleland, John G.F., Karl Swedberg, Alain Cohen‐Solal, et al.. (2000). The Euro Heart Failure Survey of The EUROHEART Survey Programme: A Survey on the Quality of Care Among Patients with Heart Failure in Europe. European Journal of Heart Failure. 2(2). 123–132. 110 indexed citations
19.
Folláth, Ferenc, Susanna Hinkka‐Yli‐Salomäki, H. Just, et al.. (1999). Dose-ranging and safety with intravenous levosimendan in low-output heart failure: experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trial. The American Journal of Cardiology. 83(12). 21–25. 21 indexed citations
20.
Haefeli, Walter E., et al.. (1991). Concentration-effect relations of 5-hydroxypropafenone in normal subjects. The American Journal of Cardiology. 67(11). 1022–1026. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evan Loh Breakdown of academic impact, for papers by Ali Ahmed Breakdown of academic impact, for papers by José Antônio Franchini Ramires Breakdown of academic impact, for papers by John D. Horowitz Breakdown of academic impact, for papers by Keld Kjeldsen Breakdown of academic impact, for papers by James E. Dalen Breakdown of academic impact, for papers by José López‐Sendón Breakdown of academic impact, for papers by Eric L. Michelson Breakdown of academic impact, for papers by Fred S. Apple Breakdown of academic impact, for papers by Emil Loldrup Fosbøl
Rankless by CCL
2026